We are live on ! Find out more
LFVN icon

LifeVantage

6.17 USD
-0.20
3.14%
At close Updated Sep 11, 4:00 PM EDT
1 day
-3.14%
5 days
0.98%
1 month
-7.36%
3 months
-34.98%
6 months
16.86%
Year to date
2.32%
1 year
-47.35%
5 years
-18.92%
10 years
-47.17%
 

About: Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product. Geographically, its products are sold in the regions of in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium and Others. The company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner.

Employees: 223

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 0%
Neutral 85.7%
Negative 14.3%
Neutral
Seeking Alpha
15 days ago
LifeVantage Corporation (LFVN) Q4 2026 Earnings Call Transcript
LifeVantage Corporation (LFVN) Q4 2026 Earnings Call Transcript
LifeVantage Corporation (LFVN) Q4 2026 Earnings Call Transcript
Negative
MarketBeat
15 days ago
Lifevantage Q4 Earnings Call Highlights
Lifevantage NASDAQ: LFVN reported lower fourth-quarter and fiscal 2026 results as the health and wellness company faced fewer orders, lower average order sizes and a difficult comparison against prior-year sales of its MindBody GLP-1 System.
Lifevantage Q4 Earnings Call Highlights
Neutral
GlobeNewsWire
15 days ago
LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026
SALT LAKE CITY, Aug. 27, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth fiscal quarter ended June 30, 2026.
LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026
Neutral
GlobeNewsWire
22 days ago
LifeVantage Declares Quarterly Dividend
SALT LAKE CITY, Aug. 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.050 per share of common stock, which will be paid September 15, 2026 to all stockholders of record at the close of business on September 1, 2026.
LifeVantage Declares Quarterly Dividend
Neutral
GlobeNewsWire
29 days ago
LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026
SALT LAKE CITY, Aug. 13, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2026, after the stock market closes on Thursday, August 27, 2026. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.
LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026
Neutral
GlobeNewsWire
1 month ago
LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SALT LAKE CITY, Aug. 11, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”) today announced that its Board of Directors granted inducement awards to Terrence Moorehead, the Company's new President and Chief Executive Officer, under the Company's 2026 New Employee Long-Term Incentive Plan (the “New Employee Plan”) as an inducement material to Mr. Moorehead's employment in accordance with Nasdaq Listing Rule 5635(c)(4).
LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Neutral
GlobeNewsWire
1 month ago
LifeVantage Welcomes Terrence Moorehead as Chief Executive Officer
SALT LAKE CITY, Aug. 05, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced Terrence Moorehead has officially joined the Company as President and Chief Executive Officer and as a member of the Board of Directors. Moorehead's appointment was previously announced on April 16, 2026.
LifeVantage Welcomes Terrence Moorehead as Chief Executive Officer
Neutral
Zacks Investment Research
3 months ago
Do Options Traders Know Something About LifeVantage Stock We Don't?
Investors need to pay close attention to LFVN stock based on the movements in the options market lately.
Do Options Traders Know Something About LifeVantage Stock We Don't?
Neutral
Seeking Alpha
4 months ago
LifeVantage Corporation (LFVN) Q3 2026 Earnings Call Transcript
LifeVantage Corporation (LFVN) Q3 2026 Earnings Call Transcript
LifeVantage Corporation (LFVN) Q3 2026 Earnings Call Transcript
Negative
Zacks Investment Research
4 months ago
Lifevantage (LFVN) Q3 Earnings and Revenues Miss Estimates
Lifevantage (LFVN) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.26 per share a year ago.
Lifevantage (LFVN) Q3 Earnings and Revenues Miss Estimates
Price charts implemented using Lightweight Charts™